Brinker A - Search Results

1

Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.

La Grenade L, Lee L, Weaver J, Bonnel R, Karwoski C, Governale L, Brinker A. La Grenade L, et al. Among authors: brinker a. Drug Saf. 2005;28(10):917-24. doi: 10.2165/00002018-200528100-00008. Drug Saf. 2005. PMID: 16180941

2

Spontaneous reports of hypertension leading to hospitalisation in association with rofecoxib, celecoxib, nabumetone and oxaprozin.

Brinker A, Goldkind L, Bonnel R, Beitz J. Brinker A, et al. Drugs Aging. 2004;21(7):479-84. doi: 10.2165/00002512-200421070-00005. Drugs Aging. 2004. PMID: 15132714

3

Chemical Leukoderma Associated with Methylphenidate Transdermal System: Data From the US Food and Drug Administration Adverse Event Reporting System.

Cheng C, La Grenade L, Diak IL, Brinker A, Levin RL. Cheng C, et al. Among authors: brinker a. J Pediatr. 2017 Jan;180:241-246. doi: 10.1016/j.jpeds.2016.09.008. Epub 2016 Oct 10. J Pediatr. 2017. PMID: 27745746 Free PMC article.

4

Renal failure associated with the use of celecoxib and rofecoxib.

Ahmad SR, Kortepeter C, Brinker A, Chen M, Beitz J. Ahmad SR, et al. Among authors: brinker a. Drug Saf. 2002;25(7):537-44. doi: 10.2165/00002018-200225070-00007. Drug Saf. 2002. PMID: 12093311 Review.

5

GI events leading to death in association with celecoxib and rofecoxib.

Weaver J, Bonnel RA, Karwoski CB, Brinker AD, Beitz J. Weaver J, et al. Among authors: brinker ad. Am J Gastroenterol. 2001 Dec;96(12):3449-50. doi: 10.1111/j.1572-0241.2001.05347.x. Am J Gastroenterol. 2001. PMID: 11774975 No abstract available.

6

Retrospective analysis of mortalities associated with medication errors.

Phillips J, Beam S, Brinker A, Holquist C, Honig P, Lee LY, Pamer C. Phillips J, et al. Among authors: brinker a. Am J Health Syst Pharm. 2001 Oct 1;58(19):1835-41. doi: 10.1093/ajhp/58.19.1835. Am J Health Syst Pharm. 2001. PMID: 11596700

7

Abuse, dependence, or withdrawal associated with tramadol.

Brinker A, Bonnel RA, Beitz J. Brinker A, et al. Am J Psychiatry. 2002 May;159(5):881; author reply 881-2. doi: 10.1176/appi.ajp.159.5.881. Am J Psychiatry. 2002. PMID: 11986164 No abstract available.

8

Profiling cumulative proportional reporting ratios of drug-induced liver injury in the FDA Adverse Event Reporting System (FAERS) database.

Brinker AD, Lyndly J, Tonning J, Moeny D, Levine JG, Avigan MI. Brinker AD, et al. Drug Saf. 2013 Dec;36(12):1169-78. doi: 10.1007/s40264-013-0116-9. Drug Saf. 2013. PMID: 24178291

9

Celecoxib and rofecoxib.

Brinker AD, Bonnel RA, Feight AG, Nourjah P. Brinker AD, et al. J Am Dent Assoc. 2001 Nov;132(11):1502, 1504. doi: 10.14219/jada.archive.2001.0065. J Am Dent Assoc. 2001. PMID: 11806062 No abstract available.

10

An observational study of cholecystectomy in patients receiving tegaserod.

Brinker A, Schech SD, Burgess M, Avigan M. Brinker A, et al. Drug Saf. 2007;30(7):581-8. doi: 10.2165/00002018-200730070-00003. Drug Saf. 2007. PMID: 17604409

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

176 results

Search Page